Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.31 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8528223 | 1.00 | ALDH1A1 (0.35) | ALDH1A1LMNAL3MBTL1TDP1TRPV1 | |
| SCHEMBL8531439 | 1.00 | ALDH1A1 (0.35) | ALDH1A1LMNAL3MBTL1TDP1TRPV1 | |
| SCHEMBL8533620 | 1.00 | ALDH1A1 (0.35) | ALDH1A1LMNAL3MBTL1TDP1TRPV1 | |
| SCHEMBL9405684 | 1.00 | ALDH1A1 (0.35) | ALDH1A1LMNAL3MBTL1TDP1TRPV1 | |
| SCHEMBL8528042 | 1.00 | ALDH1A1 (0.35) | ALDH1A1LMNAL3MBTL1TDP1TRPV1 | |
| SCHEMBL8530550 | 1.00 | ALDH1A1 (0.35) | ALDH1A1LMNAL3MBTL1TDP1TRPV1 | |
| SCHEMBL9669483 | 1.00 | ALDH1A1 (0.35) | ALDH1A1LMNAL3MBTL1TDP1TRPV1 | |
| SCHEMBL9405883 | 1.00 | ALDH1A1 (0.35) | ALDH1A1LMNAL3MBTL1TDP1TRPV1 | |
| SCHEMBL14346149 | 0.91 | — | — | |
| SCHEMBL4284663 | 0.84 | LMNA (0.44) | ALDH1A1LMNAL3MBTL1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0663391-B1 | Sulphuric acid esters of sugar alcohols for the treatment of arteriosclerotic changes in the vascular walls | HOFFMANN LA ROCHE (CH) | 1997-04-09 | — | — | EP | disclosed |
| US-5521160-A | COMPOUNDS FOR TREATMENT OF ATHERIOSCLEROSIS IN BLOOD VESSELS AND PREVENTION OF RESTENOSIS AFTER ANGIOPLASTY | HOFFMANN-LA ROCHE INC. (US) | 1996-05-28 | — | — | US | disclosed |
| EP-0663391-A1 | Sulphuric acid esters of sugar alcohols for the treatment of arteriosclerotic changes in the vascular walls | F. HOFFMANN-LA ROCHE AG (CH) | 1995-07-19 | — | — | EP | disclosed |